Detalhe da pesquisa
1.
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications.
Int J Mol Sci
; 24(13)2023 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445976
2.
Feasibility and Predictive Performance of a Triage System for Patients with Cancer During the COVID-19 Pandemic.
Oncologist
; 26(4): e694-e703, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539583
3.
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives.
Crit Rev Oncol Hematol
; 186: 104013, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37116817
4.
Estimating survival in patients with melanoma brain metastases: prognostic value of lactate dehydrogenase.
Melanoma Res
; 33(5): 398-405, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37402350
5.
In search of diverse and connected teams: A computational approach to assemble diverse teams based on members' social networks.
PLoS One
; 17(11): e0276061, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36350821
6.
Multidisciplinary Team Meeting Proposal and Final Therapeutic Choice in Early Breast Cancer: Is There an Agreement?
Front Oncol
; 12: 885992, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747814
7.
First- and second-line treatment strategies for hormone-receptor (HR)-positive HER2-negative metastatic breast cancer: A real-world study.
Breast
; 57: 104-112, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812267
8.
GU-CA-COVID: a clinical audit among Italian genitourinary oncologists during the first COVID-19 outbreak.
Ther Adv Urol
; 13: 17562872211054302, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707691
9.
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Ther Adv Med Oncol
; 12: 1758835920968463, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224275
10.
The promise and pitfalls of the metaverse for science.
Nat Hum Behav
; 7(8): 1237-1240, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37202534
11.
Number Needed to Treat in Trials of Targeted Therapies for Advanced Ovarian Cancer.
JAMA Netw Open
; 5(12): e2245077, 2022 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36459141